<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000736792">
  <TermName>iodine I 123-metaiodobenzylguanidine</TermName>
  <TermPronunciation>(I-oh-dine … meh-tuh-I-oh-doh-BEN-zul-GWAH-nih-deen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug containing a form of radioactive iodine called I 123 that is used to find certain types of tumors, including pheochromocytomas and neuroblastomas. Radiation from I 123 may help show where cancer cells are in the body. Iodine I 123-metaiodobenzylguanidine is a type of radioconjugate. Also called 123I-MIBG, AdreView, and iobenguane I 123.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000742991" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iodine I 123 metaiodobenzylguanidine&quot;" language="en" id="_4"/>
  <MediaLink ref="CDR0000742990" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;yodo I 123-metayodobencilguanidina&quot;" language="es" id="_3"/>
  <SpanishTermName>yodo I 123-metayodobencilguanidina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que contiene una forma de yodo radiactivo que se llama I 123. Se usa para detectar ciertos tipos de tumores, como los feocromocitomas y los neuroblastomas. Es posible que la radiación del I 123 ayude a identificar los lugares del cuerpo donde hay células cancerosas. El yodo I 123-metayodobencilguanidina es un tipo de radioconjugado. También se llama 123I-MIBG, AdreView e iobenguano I 123.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2012-11-01</DateFirstPublished>
  <DateLastModified>2017-10-24</DateLastModified>
</GlossaryTerm>
